Skip to Content

Publications Search - Abstract View

Title: Polymorphisms in integrin genes and lymphoma risk.
Authors: Shen M,  Zheng T,  Lan Q,  Zhang Y,  Hosgood HD 3rd,  Zahm SH,  Holford TR,  Leaderer B,  Yeager M,  Yuenger J,  Chanock S,  Rothman N
Journal: Leuk Res
Date: 2011 Jul
Branches: CGR, LTG, OD, OEEB
PubMed ID: 21239057
PMC ID: PMC3232182
Abstract: Immune deficiency is one of the best characterized and strongest known risk factors for non-Hodgkin lymphoma (NHL). We studied the association between single nucleotide polymorphisms (SNPs) in integrin genes that are important components in human innate immunity and the risk of NHL in a population-based case-control study of women in Connecticut, USA. A total of 373 tag SNPs in 33 gene regions were included in the analysis of 448 cases and 525 controls. The ADAM19 rs11466782 SNP was associated with an increased risk of lymphoma (OR, 1.73; 95% CI, 1.28-2.35; Padditive=0.0004), and the ICAM3 rs2304240 (OR, 0.67; 95% CI, 0.52-0.86; Padditive=0.002) and the PTGDR rs708486 SNPs (OR, 0.75; 95% CI, 0.63-0.90; Padditive=0.002) were associated with reduced risk of lymphoma. Two gene regions (ADAM19 (P=0.009) and ICAM3 (P=0.009)) displayed global associations with lymphoma risk at the P<0.01 level. While our results suggest that genetic polymorphisms in integrin genes may play a role in the genesis of lymphoma in women, they should be viewed as exploratory until they are replicated in additional populations.